Atopy and the gastrointestinal tract-a review of a common association in unexplained gastrointestinal disease

Expert Review of Gastroenterology and Hepatology

Volumn 8, Issue 3, 2014, Pages 289-299

  Walker, Marjorie M ^a   Powell, Nicholas ^b   Talley, Nicholas J ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

allergy; atopy; eosinophilic gastrointestinal disease; food allergy; gastrointestinal inflammation; intestinal microbiota

Indexed keywords

ALLERGENS; FOOD HYPERSENSITIVITY; GASTROINTESTINAL DISEASES; GLUTENS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOGLOBULIN E;

EID: 84894143671     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2014.881716     Document Type: Review

References (119)

1. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113(5):832-6
2. Linneberg A, Nielsen NH, Madsen F, et al. Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart: the Copenhagen Allergy Study. J Allergy Clin Immunol 2000;106(2):247-52
3. Law M, Morris JK, Wald N, et al. Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ 2005;330(7501):1187-8
4. Luckey TD. Introduction to intestinal microecology. Am J Clin Nutr 1972;25(12): 1292-4
5. Chanarin I, Rothman D, Perry J, Stratfull D. Normal dietary folate, iron, and protein intake, with particular reference to pregnancy. Br Med J 1968;2(5602):394-7
6. Durham SR, Carroll M, Walsh GM, Kay AB. Leukocyte activation in allergen-induced late-phase asthmatic reactions. N Engl J Med 1984;311(22): 1398-402
7. Pradalier A. Late-phase reaction in asthma: basic mechanisms. Int Arch Allergy Immunol 1993;101(3):322-5
8. Robinson D, Hamid Q, Bentley A, et al. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92(2):313-24
9. Varga EM, Jacobson MR, Till SJ, et al. Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis. Allergy 1999;54(4):338-45
10. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992; 90(2):184-93
11. Wambre E, James EA, Kwok WW. Characterization of CD4+ T cell subsets in allergy. Curr Opin Immunol 2012;24(6): 700-6
12. Battaglia M, Gianfrani C, Gregori S, Roncarolo MG. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann NY Acad Sci 2004;1029:142-53
13. Bellinghausen I, Konig B, Bottcher I, et al. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction. Clin Exp Allergy 2006;36(12): 1546-55
14. Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363(9409): 608-15
15. Grindebacke H, Wing K, Andersson AC, et al. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004;34(9): 1364-72
16. Carlier VA, Vanderelst LP, Jacquemin MG, Saint-Remy JM. Regulatory CD4+ T cells in allergic asthma. Expert Rev Clin Immunol 2006;2(5):737-44
17. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002;39(8):537-45
18. Maurer D, Fiebiger S, Ebner C, et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157(2):607-16
19. Hammad H, Plantinga M, Deswarte K, et al. Inflammatory dendritic cells - not basophils - are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 2010; 207(10):2097-111
20. Chand HS, Schuyler M, Joste N, et al. Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways. J Allergy Clin Immunol 2010;125(5): 1157-8; e1155
21. Schroeder JT, Bieneman AP, Chichester KL, et al. Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization. J Allergy Clin Immunol 2010;125(4):896-901.e896
22. Hill DJ, Hosking CS. Food allergy and atopic dermatitis in infancy: an epidemiologic study. Pediatr Allergy Immunol 2004;15(5):421-7
23. Roberts G, Patel N, Levi-Schaffer F, et al. Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol 2003;112(1):168-74
24. Lack G. Clinical practice. Food allergy. N Engl J Med 2008;359(12):1252-60
25. Dolovich J, Hargreave FE, Jordana M, Denburg J. Late-phase airway reaction and inflammation. J Allergy Clin Immunol 1989;83(2 Pt 2):521-4
26. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004;113(1):11-28.quiz 29
27. Spergel JM, Book WM, Mays E, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr 2011;52(3):300-6
28. Spergel JM, Brown-Whitehorn TF, Cianferoni A, et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 2012;130(2):461-7; e465
29. Lucendo AJ, Arias A, Gonzalez-Cervera J, et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol 2013;131(3):797-804
30. Odze RD, Bines J, Leichtner AM, et al. Allergic proctocolitis in infants: a prospective clinicopathologic biopsy study. Hum Pathol 1993;24(6):668-74
31. Kato M, Kephart GM, Talley NJ, et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998; 252(3):418-25
32. Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001;108(6):954-61
33. Vicario M, Blanchard C, Stringer KF, et al. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 2010;59(1):12-20
34. Blanchard C, Stucke EM, Rodriguez-Jimenez B, et al. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol 2011;127(1):208-17.217.e201-7
35. Yamazaki K, Murray JA, Arora AS, et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci 2006; 51(11):1934-41
36. Jaffe JS, James SP, Mullins GE, et al. Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol 1994;14(5):299-309
37. Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 2012;10:13
38. Zauli D, Grassi A, Granito A, et al. Prevalence of silent coeliac disease in atopics. Dig Dis Sci 2000;32(9):775-9
39. Greco L, De Seta L, D'Adamo G, et al. Atopy and coeliac disease: bias or true relation? Acta paediatr Scand 1990;79(6-7): 670-4
40. Verkasalo M, Tiilikainen A, Kuitunen P, et al. HLA antigens and atopy in children with coeliac disease. Gut 1983;24(4):306-10
41. Ciacci C, Cavallaro R, Iovino P, et al. Allergy prevalence in adult celiac disease. J Allergy Clin Immunol 2004;113(6): 1199-203
42. Hodgson HJ, Davies RJ, Gent AE. Atopic disorders and adult coeliac disease. Lancet 1976;1(7951):115-17
43. Massari S, Liso M, De Santis L, et al. Occurrence of nonceliac gluten sensitivity in patients with allergic disease. Int Arch Allergy Immunol 2011;155(4):389-94
44. Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012;107(12):1898-906.quiz 1907
45. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142(1):46-54.e42 quiz e30
46. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005;129(3):827-36
47. Hammer B, Ashurst P, Naish J. Diseases associated with ulcerative colitis and Crohn's disease. Gut 1968;9(1):17-21
48. Jewell DP, Truelove SC. Reaginic hypersensitivity in ulcerative colitis. Gut 1972;13(11):903-6
49. Roberts DL, Rhodes J, Heatley RV, Newcombe RG. Atopic features in ulcerative colitis. Lancet 1978;1(8076):1262
50. Myrelid P, Dufmats M, Lilja I, et al. Atopic manifestations are more common in patients with Crohn disease than in the general population. Scand J Gastroenterol 2004; 39(8):731-6
51. Rowe AH. Chronic ulcerative colitis, an allergic disease. Ann Allergy 1949;7(6): 727-51
52. Levo Y, Shalit M, Wollner S, Fich A. Serum IgE levels in patients with inflammatory bowel disease. Ann Allergy 1986;56(1):85-7
53. Brignola C, Miniero R, Campieri M, et al. Dietary allergy evaluated by PRIST and RAST in inflammatory bowel disease. Hepatogastroenterology 1986;33(3):128-30
54. Patel P, Brostoff J, Campbell H, et al. Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease. Clin Transl Allergy 2013;3(1):26
55. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) 1984;288(6434):1859-62
56. Woodruff SA, Masterson JC, Fillon S, et al. Role of eosinophils in inflammatory bowel and gastrointestinal diseases. J Pediatr Gastroenterol Nutr 2011;52(6):650-61
57. Luck W, Becker M, Niggemann B, Wahn U. In vitro release of eosinophil cationic protein from peripheral eosinophils reflects disease activity in childhood Crohn disease and ulcerative colitis. Eur J Pediatr 1997;156(12):921-4
58. Carvalho AT, Elia CC, de Souza HS, et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003;36(2):120-5
59. Bischoff SC, Mayer J, Nguyen QT, et al. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol 1999;94(12):3521-9
60. Berstad A, Borkje B, Riedel B, et al. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepatogastroenterology 1993;40(3):276-8
61. Saitoh O, Kojima K, Sugi K, et al. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am J Gastroenterol 1999;94(12): 3513-20
62. Chen W, Paulus B, Shu D. Wilson, Chadwick V. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand J Gastroenterol 2001;36(5): 515-20
63. Ahrens R, Waddell A, Seidu L, et al. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol 2008;181(10): 7390-9
64. Furuta GT, Nieuwenhuis EE, Karhausen J, et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol 2005;289(5):G890-7
65. Forbes E, Murase T, Yang M, et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol 2004;172(9): 5664-75
66. Smyth CM, Akasheh N, Woods S, et al. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 2013;8(5):e64216
67. Louis E, Louis R, Shute J, et al. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 1999;29(5):660-6
68. Fireman E, Masarwy F, Groisman G, et al. Induced sputum eosinophilia in ulcerative colitis patients: the lung as a mirror image of intestine? Respir Med 2009;103(7): 1025-32
69. Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007; 56(12):1654-64
70. American Lung Association Asthma Clinical Research Centers. Mastronarde JG, Anthonisen NR, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360(15):1487-99
71. Kiljander TO, Laitinen JO. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 2004;126(5):1490-4
72. Onbasi K, Sin AZ, Doganavsargil B, et al. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 2005; 35(11):1423-31
73. Powell N, Huntley B, Beech T, Knight W. Upper gastrointestinal symptoms and asthma: a manifestation of allergy? Gut 2008;57(7):1026-7
74. Untersmayr E, Bakos N, Scholl I, et al. Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. FASEB J 2005;19(6):656-8
75. Untersmayr E, Scholl I, Swoboda I, et al. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy Clin Immunol 2003;112(3):616-23
76. Powell N, Huntley B, Beech T, et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J 2007;83(977):182-6
77. Tobin MC, Moparty B, Farhadi A, et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol 2008;100(1):49-53
78. Kennedy TM, Jones RH, Hungin AP, et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998;43(6): 770-4
79. Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009;29(7):765-73
80. Guilarte M, Santos J, de Torres I, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007;56(2):203-9
81. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993;38(9):1590-5
82. O'Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12(5):449-57
83. Talley NJ, Walker MM, Aro P, et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007;5(10):1175-83
84. Walker MM, Salehian SS, Murray CE, et al. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther 2010;31(11): 1229-36
85. Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2013. [Epub ahead of print]
86. Shulman RJ, Eakin MN, Czyzewski DI, et al. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr 2008;153(5): 646-50
87. Wallaert B, Desreumaux P, Copin MC, et al. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med 1995;182(6):1897-904
88. Burri PH. Fetal and postnatal development of the lung. Annu Rev Physiol 1984;46: 617-28
89. Silverpil E, Linden A. IL-17 in human asthma. Expert Rev Respir Med 2012;6(2): 173-86
90. Shaw DE, Berry MA, Hargadon B, et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 2007;132(6): 1871-5
91. Cosmi L, Maggi L, Santarlasci V, et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010;125(1):222-30. e221-224
92. Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 1993;147(2): 291-5
93. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103(2): 175-83
94. Yu M, Eckart MR, Morgan AA, et al. Identification of an IFN-gamma/mast cell axis in a mouse model of chronic asthma. J Clin Invest 2011;121(8):3133-43
95. Fuss IJ, Heller F, Boirivant M, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 2004;113(10):1490-7
96. Heller F, Fuss IJ, Nieuwenhuis EE, et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002;17(5):629-38
97. Bailey JR, Bland PW, Tarlton JF, et al. IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells? PLoS One 2012; 7(12):e52332
98. Ramasamy A, Kuokkanen M, Vedantam S, et al. Genome-wide association studies of asthma in population-based cohorts confirm known and suggested loci and identify an additional association near HLA. PLoS One 2012;7(9):e44008
99. Bonnelykke K, Matheson MC, Pers TH, et al. Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization. Nat Genet 2013;45(8):902-6
100. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491(7422):119-24
101. Zucchelli M, Camilleri M, Andreasson AN, et al. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 2011;60(12):1671-7
102. Villani AC, Lemire M, Thabane M, et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010;138(4):1502-13
103. Lauener RP, Birchler T, Adamski J, et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002;360(9331):465-6
104. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357(17):1731-43
105. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299(6710): 1259-60
106. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009;7(12): 887-94
107. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486(7402):207-14
108. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107(26):11971-5
109. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486(7402): 222-7
110. Candela M, Rampelli S, Turroni S, et al. Unbalance of intestinal microbiota in atopic children. BMC Microbiol 2012;12:95
111. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104(34):13780-5
112. Rajilic-Stojanovic M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011;141(5):1792-801
113. Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 2011;128(3): 646-52.e641-645
114. Penders J, Stobberingh EE, van den Brandt PA, Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007;62(11): 1223-36
115. Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139(3):485-98
116. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011;108(Suppl 1):4615-22
117. Wu HJ. Ivanov, II, Darce J, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010;32(6):815-27
118. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013;500(7461): 232-6
119. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011;117(3):1061-70